
Pharma News
-
Cp Tianqing plans to sell three subsidiaries
2022-12-23Nanjing Pharmaceutical plans to acquire part or all of CP Tianqing's three controlling subsidiaries.
-
Reindeer Biological self - developed CT103A clinical trial application approved by FDA!
2022-12-23The approval of the CT103A US IND is an important milestone in the internationalization of reindeer biology.
-
Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted
2022-12-23It can treat a variety of solid tumors.
-
Fosun Kat FKC889 was approved for clinical trials
2022-12-23For the treatment of relapsed or refractory adult precursor B-cell acute lymphoblastic leukemia.
-
Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species
2022-12-22After assessment, the Panel was unable to reach a conclusion on the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species.
-
The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens
2022-12-22European Union animal Feed Additives and Products (FEEDAP) research group issued A scientific opinion on the safety of lasalocid A sodium asa dietary additive for fattening chickens and laying hens.
-
National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching
2022-12-22We will do a good job in medical insurance at the end of the year and the beginning of the year, steadily advance the centralized procurement of dental implant consumables, and complete the adjustment of the 2022 medical insurance drug list.
-
Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted
2022-12-22Asc 41 is a liver targeting precursor drug independently developed by Golly.
-
ASKG915 for Injection, a subsidiary of AskG915, was approved in the US
2022-12-22Intended for advanced solid tumors.
-
Advanced liver cancer treatment new progress! The oncolytic virus drug VG161 has remarkable clinical effect
2022-12-22New progress in the treatment of advanced liver cancer.
-
Fubicide vaccine was approved for official registration in Hong Kong, China
2022-12-22Fubicide vaccine has better immunogenicity and broad spectrum.
-
What if you can't get acetaminophen?
2022-12-22It is also the main ingredient in many cold remedies.
-
Clover Liang Peng: How to bring the patented technology 'home' to achieve the dark horse of COVID-19 vaccine?
2022-12-22With this discovery, he established the past and future of clover life.
-
Junsil Biologics has opened new VV116 and Pfizer Paxlovid head-to-head phase III clinical trials
2022-12-22The development of "special drugs" for COVID-19 has entered the fast track again.
-
Can PROTAC Grab a slice of the $50 billion market for self-medicated drugs?
2022-12-22PROTAC enters the non-cancer arena
-
Merck's new generation of antifungal drug Posaconazole inJ has been launched in China
2022-12-22It is used to prevent invasive aspergillus and candida infection and to treat invasive aspergillus disease.
-
Pfizer and LianBio have entered into a collaboration agreement on respiratory syncytial virus therapeutic candidates
2022-12-20Pfizer and LianBio have reached a collaboration agreement on respiratory syncytial virus treatment candidates.
-
Hutchison Pharmaceutical: Fruquintinib submitted a rolling marketing application to the FDA
2022-12-20Hutchison Pharma owns all commercialization rights of fruquintinib outside of China.
-
Nearly $4 billion in gambling, revealing the top ten licenses in 2022
2022-12-19Under the capital winter, the cross-border license in of domestic pharmaceutical companies has also been affected to a certain extent.
-
Can the concept of 'new crown miracle drug' ursodeoxycholic acid set off a new round of research and development?
2022-12-19What is the domestic ursodeoxycholic acid market?
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan